What is Nplate (romiplostim) by Amgen?
Nplate is Amgen’s brand of romiplostim, a medicine used to treat certain forms of low platelet counts (thrombocytopenia) in patients who have an inadequate response to other treatments. It works by stimulating platelet production. [1][2]
What conditions is Nplate used for?
Nplate is prescribed for thrombocytopenia in specific clinical settings, including chronic immune (idiopathic) thrombocytopenic purpura (ITP), and it is also used in other approved indications depending on country and patient profile. [1][2]
How is Nplate given and how is dosing handled?
Nplate is given as a subcutaneous (under-the-skin) injection. Dosing is individualized and adjusted based on platelet response to reduce the risk of having platelet counts that are too high. [1][2]
What are common side effects patients ask about?
Commonly reported side effects can include headache, dizziness, joint pain, nausea, and fatigue, with additional risks tied to platelet count changes. [1][2]
What serious risks are associated with Nplate?
Because Nplate increases platelet counts, serious risks can include complications related to overly high platelet levels and other safety concerns described in prescribing information. [1][2]
How does Nplate compare with other ITP treatments?
Nplate is one of several thrombopoietin receptor agonists used in ITP. Choice among options can depend on patient history, previous response, dosing preferences, and safety considerations described in each product’s prescribing information. [1][2]
Who makes Nplate and who markets it?
Nplate is made by Amgen. The brand and product documentation are associated with Amgen’s development and commercialization of romiplostim. [1][2]
---
Sources:
[1] https://www.amgen.com/
[2] https://www.nplate.com/